V G Crowe

In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides.

Raymond F. Kauffman, Kathryn W. Schenck, B G Utterback et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 124 citations

Medicine, Medicinal Chemistry, Pharmacology +15

LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum.

Raymond F. Kauffman, V G Crowe, B G Utterback et al. · Molecular Pharmacology · 1986 · 84 citations

Life Sciences, Biochemistry, Pharmacology +16

Thrombolytic activity of a novel plasminogen activator, LY210825, compared with recombinant tissue-type plasminogen activator in a canine model of coronary artery thrombosis.

Charles V. Jackson, V G Crowe, Trelia J. Craft et al. · Circulation · 1990 · 32 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +13

Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.

Charles V. Jackson, V G Crowe, Judit Frank et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 28 citations

Medicine, Cardiology, Pharmacology +16

Effect of Ionic Calcium and Magnesium on Human Platelet Aggregation

Roy Herrmann, William B. Lacefield, V G Crowe · Experimental Biology and Medicine · 1970 · 23 citations

Medicine, Biochemistry, Cell Biology +12